By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CEL-SCI Corporation 

8229 Boone Boulevard
Suite 802
Vienna  Virginia  22182  U.S.A.
Phone: 703-506-9460 Fax: 703-506-9471


Company News
CEL-SCI (CVM) Scientist Presents New Findings For Rheumatoid Arthritis Treatment Vaccine At Conference 2/21/2017 8:43:48 AM
CEL-SCI (CVM) Announces $1.0 Million Registered Direct Offering 2/17/2017 7:11:19 AM
CEL-SCI (CVM) Corporation Reports First Quarter Fiscal 2017 Financial Results 2/10/2017 6:41:22 AM
CEL-SCI (CVM) Announces Closing Of Public Offering And Receives Audit Opinion With Going Concern Explanation 12/21/2016 11:58:15 AM
CEL-SCI (CVM) Reports Fiscal 2016 Financial Results And Clinical & Corporate Developments 12/15/2016 11:03:13 AM
CEL-SCI (CVM) Reports On NYSE MKT Noncompliance Notice And Compliance Plan 12/12/2016 10:50:55 AM
CEL-SCI (CVM) Announces Proposed Public Offering Of Common Stock And Warrants 12/2/2016 11:17:11 AM
CEL-SCI (CVM) Announces Pricing Of $4.25 Million Public Offering Of Common Stock And Warrants 12/2/2016 10:57:25 AM
CEL-SCI (CVM) Submits Response To FDA In Connection With Partial Clinical Hold On Phase III Clinical Trial 11/21/2016 11:07:13 AM
CEL-SCI (CVM) Reports Preclinical Data Showing LEAPS Vaccine Is Successful In Treating Rheumatoid Arthritis 11/14/2016 10:53:23 AM